Tahir Amin

Initiative for Medicines, Access & Knowledge (I-MAK)

India

  • Initiative for Medicines, Access & Knowledge (I-MAK)

SCHOLARLY PAPERS

2

DOWNLOADS

149

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Whether and How the U.S. Government Should Exercise Its Compulsory Licensing Authority Under 28 U.S.C. § 1498 and the Bayh-Dole Act

NYU Journal of Intellectual Property & Entertainment Law, 11, U of Michigan Public Law Research Paper 21-036, Duke Law School Public Law & Legal Theory Series No. 2022-07
Number of pages: 25 Posted: 18 Nov 2021 Last Revised: 09 Feb 2022
Arti K. Rai, Rebecca S. Eisenberg, Tahir Amin, Henry Hadad and Rachel Sachs
Duke University School of Law, University of Michigan Law School, Initiative for Medicines, Access & Knowledge (I-MAK), affiliation not provided to SSRN and Washington University in Saint Louis - School of Law
Downloads 149 (378,100)

Abstract:

Loading...

Symposium, Access, Medicine, COVID, Coronavirus, NYU, Prescription, Drugs, Government, Healthcare, Insurance, Research, Pharmaceutical, Pharma, NIH, Pandemic, Vaccine, Patent, Intellectual Property, IP, Licensing, 28 U.S.C. § 1498, Bayh-Dole Act, Public Health, Biomedical, Bioethics, Policy

2.

Expert Review of Drug Patent Applications: Improving Health in the Developing World

Health Affairs, Vol. 28, No. 5, 2009
Posted: 22 Nov 2009
Tahir Amin, Rahul Rajkumar, Priti Radhakrishnan and Aaron S. Kesselheim
Initiative for Medicines, Access & Knowledge (I-MAK), Harvard University - Brigham and Women's Hospital, Initiative for Medicines, Access & Knowledge (I-MAK) and Brigham and Women's Hospital/Harvard Medical School

Abstract:

Loading...

patents, TDF, Indian patent act, TRIPS agreement